Page last updated: 2024-08-17

dichlororibofuranosylbenzimidazole and eye

dichlororibofuranosylbenzimidazole has been researched along with eye in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eskin, A; Koumenis, C; Nunez-Regueiro, M; Raju, U1
Eskin, A; Koumenis, C; Tran, Q1
Page, TL1

Other Studies

3 other study(ies) available for dichlororibofuranosylbenzimidazole and eye

ArticleYear
Alteration of the phase and period of a circadian oscillator by a reversible transcription inhibitor.
    Science (New York, N.Y.), 1991, Aug-09, Volume: 253, Issue:5020

    Topics: Animals; Aplysia; Camptothecin; Circadian Rhythm; Dichlororibofuranosylbenzimidazole; Eye; In Vitro Techniques; Ocular Physiological Phenomena; Time Factors; Transcription, Genetic; Uridine

1991
The use of a reversible transcription inhibitor, DRB, to investigate the involvement of specific proteins in the ocular circadian system of Aplysia.
    Journal of biological rhythms, 1996, Volume: 11, Issue:1

    Topics: Animals; Aplysia; Autoradiography; Circadian Rhythm; Dichlororibofuranosylbenzimidazole; Electrophoresis, Polyacrylamide Gel; Eye; Kinetics; Leucine; Nerve Tissue Proteins; Ocular Physiological Phenomena; Optic Nerve; Transcription, Genetic; Uridine

1996
A novel mechanism for the control of circadian clock period by light.
    Journal of biological rhythms, 2000, Volume: 15, Issue:2

    Topics: Action Potentials; Animals; Biological Clocks; Cycloheximide; Dichlororibofuranosylbenzimidazole; Eye; Light; Mollusca; Nervous System Physiological Phenomena; Nucleic Acid Synthesis Inhibitors; Protein Biosynthesis; Protein Synthesis Inhibitors; Transcription, Genetic

2000